CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Dexamethasone

地塞米松 杂质对照品Dexamethasone Impurities

EP59 个杂质条目59 impurity entries

本页汇总 地塞米松 的 59 个杂质对照品条目,其中药典杂质标注了 EP/USP 编号。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 59 impurity reference standards of Dexamethasone with EP/USP numbering where applicable. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 地塞米松(Dexamethasone)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesStability and compatibility of methotrexate and dexamethasone in 0.9% sodium chloride for intrathecal injection
    Pakistan journal of pharmaceutical sciences · 2020 · Xu F, Zeng S  ·  PMID 33867319
  2. 杂质研究Impurity studiesStability of dexamethasone sodium phosphate in rat plasma
    International journal of pharmaceutics · 2005 · Samtani MN, Jusko WJ  ·  PMID 16054309  ·  DOI
  3. 分析方法Analytical MethodsA validated, stability-indicating HPLC method for the determination of dexamethasone related substances on dexamethasone-coated drug-eluting stents
    Journal of pharmaceutical and biomedical analysis · 2008 · Chen Q et al.  ·  PMID 18722070  ·  DOI
  4. 分析方法Analytical MethodsDevelopment and Validation of Facile RP-HPLC Method for Simultaneous Determination of Timolol Maleate, Moxifloxacin Hydrochloride, Diclofenac Sodium and Dexamethasone in Plasma, Aqueous Humor and Pharmaceutical Products
    Journal of chromatographic science · 2023 · Shahzad A et al.  ·  PMID 35870199  ·  DOI
  5. 分析方法Analytical MethodsHPLC-UV method development and validation for anticancer drug sorafenib and the co-prescribed drug dexamethasone: application to pharmacokinetic evaluation of sorafenib nanoformulations
    Frontiers in pharmacology · 2025 · Mateen A et al.  ·  PMID 40271069  ·  DOI

地塞米松 —— 原料药与杂质对照品Dexamethasone — drug substance & impurities

共 59 个条目(含原料药本体)59 items incl. the drug substance
Dexamethasone Impurity 3(Dexamethasone EP Impurity C) structure
EPC
地塞米松杂质3(地塞米松EP杂质C)Dexamethasone Impurity 3(Dexamethasone EP Impurity C)
Dexamethasone Impurity 3(Dexamethasone EP Impurity C)
CAS No.426-17-5
Chemical FormulaC22H31FO5
Purity>95%询价On request
10mg25mg50mg100mg
Dexamethasone Impurity 4(Dexamethasone EP Impurity D) structure
EPD
地塞米松杂质4(地塞米松EP杂质D)Dexamethasone Impurity 4(Dexamethasone EP Impurity D)
Dexamethasone Impurity 4(Dexamethasone EP Impurity D)
CAS No.24916-90-3
Chemical FormulaC22H28O5
Purity>95%询价On request
10mg25mg50mg100mg
Dexamethasone Impurity 5 (Dexamethasone EP Impurity E) structure
EPE
地塞米松杂质5 (地塞米松EP杂质E)Dexamethasone Impurity 5 (Dexamethasone EP Impurity E)
Dexamethasone Impurity 5 (Dexamethasone EP Impurity E)
CAS No.13209-41-1
Chemical FormulaC22H28O4
Purity>95%询价On request
10mg25mg50mg100mg
Dexamethasone Impurity 6 (Dexamethasone EP Impurity F) (Desoxymetasone) structure
EPF
地塞米松杂质6 (地塞米松EP杂质F) (去羟米松)Dexamethasone Impurity 6 (Dexamethasone EP Impurity F) (Desoxymetasone)
Dexamethasone Impurity 6 (Dexamethasone EP Impurity F) (Desoxymetasone)
CAS No.382-67-2
Chemical FormulaC22H29FO4
Purity>95%询价On request
10mg25mg50mg100mg
Dexamethasone EP Impurity G structure
EPG
地塞米松EP杂质GDexamethasone EP Impurity G
Dexamethasone EP Impurity G
CAS No.1177-87-3
Chemical FormulaC24H31FO6
Purity>95%现货In stock
10mg25mg50mg100mg
Dexamethasone Impurity 8 (Dexamethasone EP Impurity H) structure
EPH
地塞米松杂质8 (地塞米松EP杂质H)Dexamethasone Impurity 8 (Dexamethasone EP Impurity H)
Dexamethasone Impurity 8 (Dexamethasone EP Impurity H)
CAS No.10106-41-9
Chemical FormulaC24H30O5
Purity>95%询价On request
10mg25mg50mg100mg
Dexamethasone Impurity 9 (Dexamethasone EP Impurity I) structure
EPI
地塞米松杂质9 (地塞米松EP杂质I)Dexamethasone Impurity 9 (Dexamethasone EP Impurity I)
Dexamethasone Impurity 9 (Dexamethasone EP Impurity I)
CAS No.14622-47-0
Chemical FormulaC22H28O5
Purity>95%询价On request
10mg25mg50mg100mg
Dexamethasone Impurity 10(Dexamethasone EP Impurity J) structure
EPJ
地塞米松杂质10(地塞米松EP杂质J)Dexamethasone Impurity 10(Dexamethasone EP Impurity J)
Dexamethasone Impurity 10(Dexamethasone EP Impurity J)
CAS No.2036-77-3
Chemical FormulaC22H28O5
Purity>95%询价On request
10mg25mg50mg100mg
Dexamethasone Impurity 11(Dexamethasone EP Impurity K) structure
EPK
地塞米松杂质11(地塞米松EP杂质K)Dexamethasone Impurity 11(Dexamethasone EP Impurity K)
Dexamethasone Impurity 11(Dexamethasone EP Impurity K)
CAS No.1809224-82-5
Chemical FormulaC22H26O4
Purity>95%询价On request
10mg25mg50mg100mg
Dexamethasone Impurity 12 structure
12
地塞米松杂质12Dexamethasone Impurity 12
Dexamethasone Impurity 12
CAS No.55879-47-5
Chemical FormulaC22H29FO6
Purity>95%询价On request
10mg25mg50mg100mg
Dexamethasone Impurity 13 structure
13
地塞米松杂质13Dexamethasone Impurity 13
Dexamethasone Impurity 13
CAS No.1880-61-1
Chemical FormulaC20H25FO3
Purity>95%询价On request
10mg25mg50mg100mg
Dexamethasone Impurity 14 structure
14
地塞米松杂质14Dexamethasone Impurity 14
Dexamethasone Impurity 14
CAS No.15423-89-9
Chemical FormulaC25H33FO6
Purity>95%询价On request
10mg25mg50mg100mg
Dexamethasone Impurity 15 structure
15
地塞米松杂质15Dexamethasone Impurity 15
Dexamethasone Impurity 15
CAS No.3793-10-0
Chemical FormulaC25H33FO6
Purity>95%询价On request
10mg25mg50mg100mg
Dexamethasone Impurity 16 structure
16
地塞米松杂质16Dexamethasone Impurity 16
Dexamethasone Impurity 16
CAS No.55541-30-5
Chemical FormulaC28H37FO7
Purity>95%询价On request
10mg25mg50mg100mg
Dexamethasone Impurity 17 structure
17
地塞米松杂质17Dexamethasone Impurity 17
Dexamethasone Impurity 17
CAS No.59860-99-0
Chemical FormulaC22H27FO4
Purity>95%询价On request
10mg25mg50mg100mg
Dexamethasone Impurity 19 structure
19
地塞米松杂质19Dexamethasone Impurity 19
Dexamethasone Impurity 19
CAS No.2991360-83-7
Chemical FormulaC23H31FO5
Purity>95%询价On request
10mg25mg50mg100mg
Dexamethasone Impurity 20 CRS(Dexamethasone Palmitate CRS) structure
20
地塞米松杂质20 CRS(地塞米松棕榈酸酯 CRS)Dexamethasone Impurity 20 CRS(Dexamethasone Palmitate CRS)
Dexamethasone Impurity 20 CRS(Dexamethasone Palmitate CRS)
CAS No.14899-36-6
Chemical FormulaC38H59FO6
Purity>95%询价On request
10mg25mg50mg100mg
Dexamethasone Impurity 21 structure
21
地塞米松杂质21Dexamethasone Impurity 21
Dexamethasone Impurity 21
CAS No.432-54-2
Chemical FormulaC22H31FO4
Purity>95%询价On request
10mg25mg50mg100mg
Dexamethasone Impurity 22 structure
22
地塞米松杂质22Dexamethasone Impurity 22
Dexamethasone Impurity 22
CAS No.1926-94-9
Chemical FormulaC37H53FO8
Purity>95%询价On request
10mg25mg50mg100mg
Dexamethasone Impurity 23 structure
23
地塞米松杂质23Dexamethasone Impurity 23
Dexamethasone Impurity 23
CAS No.75262-69-0
Chemical FormulaC21H27FO4
Purity>95%询价On request
10mg25mg50mg100mg
Dexamethasone Impurity 24 structure
24
地塞米松杂质24Dexamethasone Impurity 24
Dexamethasone Impurity 24
CAS No.2964-79-6
Chemical FormulaC22H27FO5
Purity>95%询价On request
10mg25mg50mg100mg
Dexamethasone Impurity 25 structure
25
地塞米松杂质25Dexamethasone Impurity 25
Dexamethasone Impurity 25
CAS No.84449-15-0
Chemical FormulaC22H27FO6
Purity>95%询价On request
10mg25mg50mg100mg
Dexamethasone Impurity 26 structure
26
地塞米松杂质26Dexamethasone Impurity 26
Dexamethasone Impurity 26
CAS No.2964-81-0
Chemical FormulaC22H27FO5
Purity>95%询价On request
10mg25mg50mg100mg
Dexamethasone Impurity 27 structure
27
地塞米松杂质27Dexamethasone Impurity 27
Dexamethasone Impurity 27
CAS No.473273-03-9
Chemical FormulaC23H31FO6
Purity>95%询价On request
10mg25mg50mg100mg
Dexamethasone Impurity 28 structure
28
地塞米松杂质28Dexamethasone Impurity 28
Dexamethasone Impurity 28
CAS No.33755-46-3
Chemical FormulaC27H37FO6
Purity>95%询价On request
10mg25mg50mg100mg
Dexamethasone Impurity 29 structure
29
地塞米松杂质29Dexamethasone Impurity 29
Dexamethasone Impurity 29
CAS No.6762-51-2
Chemical FormulaC22H27FO4
Purity>95%询价On request
10mg25mg50mg100mg
Dexamethasone Impurity 31 structure
31
地塞米松杂质31Dexamethasone Impurity 31
Dexamethasone Impurity 31
CAS No.103374-59-0
Chemical FormulaC23H30O5
Purity>95%询价On request
10mg25mg50mg100mg
Dexamethasone Impurity 32 structure
32
地塞米松杂质32Dexamethasone Impurity 32
Dexamethasone Impurity 32
CAS No.134429-25-7
Chemical FormulaC22H28O6
Purity>95%询价On request
10mg25mg50mg100mg
Dexamethasone Impurity 33 structure
33
地塞米松杂质33Dexamethasone Impurity 33
Dexamethasone Impurity 33
CAS No.37926-77-5
Chemical FormulaC23H31FO5
Purity>95%询价On request
10mg25mg50mg100mg
Dexamethasone Impurity 34 structure
34
地塞米松杂质34Dexamethasone Impurity 34
Dexamethasone Impurity 34
CAS No.887110-95-4
Chemical FormulaC22H26I2O4
Purity>95%询价On request
10mg25mg50mg100mg
Dexamethasone Impurity 35 structure
35
地塞米松杂质35Dexamethasone Impurity 35
Dexamethasone Impurity 35
CAS No.1246744-54-6
Chemical FormulaC22H26FIO4
Purity>95%询价On request
10mg25mg50mg100mg
Dexamethasone Impurity 36 structure
36
地塞米松杂质36Dexamethasone Impurity 36
Dexamethasone Impurity 36
CAS No.2102851-76-1
Chemical FormulaC22H29FO6
Purity>95%询价On request
10mg25mg50mg100mg
Dexamethasone Impurity 37 structure
37
地塞米松杂质37Dexamethasone Impurity 37
Dexamethasone Impurity 37
CAS No.111897-35-9
Chemical FormulaC22H29FO6
Purity>95%询价On request
10mg25mg50mg100mg
Dexamethasone Impurity 38 structure
38
地塞米松杂质38Dexamethasone Impurity 38
Dexamethasone Impurity 38
CAS No.116522-68-0
Chemical FormulaC22H27FO6
Purity>95%询价On request
10mg25mg50mg100mg
Dexamethasone Impurity 39 structure
39
地塞米松杂质39Dexamethasone Impurity 39
Dexamethasone Impurity 39
CAS No.151265-33-7
Chemical FormulaC22H28O4
Purity>95%询价On request
10mg25mg50mg100mg
Dexamethasone Impurity 41 structure
41
地塞米松杂质41Dexamethasone Impurity 41
Dexamethasone Impurity 41
CAS No.473273-04-0
Chemical FormulaC22H27FO6
Purity>95%询价On request
10mg25mg50mg100mg
Dexamethasone Impurity 44 structure
44
地塞米松杂质44Dexamethasone Impurity 44
Dexamethasone Impurity 44
CAS No.1174035-75-6
Chemical FormulaC22H27FO4
Purity>95%询价On request
10mg25mg50mg100mg
Dexamethasone Impurity 47 structure
47
地塞米松杂质47Dexamethasone Impurity 47
Dexamethasone Impurity 47
CAS No.1184871-61-1
Chemical FormulaC22H29FO6
Purity>95%询价On request
10mg25mg50mg100mg
Dexamethasone Impurity 48 structure
48
地塞米松杂质48Dexamethasone Impurity 48
Dexamethasone Impurity 48
CAS No.2347478-54-8
Chemical FormulaC22H28O5
Purity>95%询价On request
10mg25mg50mg100mg
Dexamethasone Impurity 49 structure
49
地塞米松杂质49Dexamethasone Impurity 49
Dexamethasone Impurity 49
CAS No.2282-51-1
Chemical FormulaC22H27FO5
Purity>95%询价On request
10mg25mg50mg100mg
Dexamethasone Impurity 50 (Dexamethasone laurate) structure
50
地塞米松杂质50 (地塞米松月桂酸酯)Dexamethasone Impurity 50 (Dexamethasone laurate)
Dexamethasone Impurity 50 (Dexamethasone laurate)
CAS No.149793-68-0
Chemical FormulaC34H51FO6
Purity>95%询价On request
10mg25mg50mg100mg
Dexamethasone Impurity 51 (Dexamethasone myristate) structure
51
地塞米松杂质51 (地塞米松肉豆蔻酸酯)Dexamethasone Impurity 51 (Dexamethasone myristate)
Dexamethasone Impurity 51 (Dexamethasone myristate)
CAS No.81040-59-7
Chemical FormulaC36H55FO6
Purity>95%询价On request
10mg25mg50mg100mg
Dexamethasone Impurity 52 (Dexamethasone pentadecanoate) structure
52
地塞米松杂质52 (地塞米松十五烷酸酯)Dexamethasone Impurity 52 (Dexamethasone pentadecanoate)
Dexamethasone Impurity 52 (Dexamethasone pentadecanoate)
CAS No.149817-93-6
Chemical FormulaC37H57FO6
Purity>95%询价On request
10mg25mg50mg100mg
Dexamethasone Impurity 54 (Dexamethasone stearate) structure
54
地塞米松杂质54 (地塞米松硬脂酸酯)Dexamethasone Impurity 54 (Dexamethasone stearate)
Dexamethasone Impurity 54 (Dexamethasone stearate)
CAS No.81040-58-6
Chemical FormulaC40H63FO6
Purity>95%询价On request
10mg25mg50mg100mg
Dexamethasone Impurity 56 structure
56
地塞米松杂质56Dexamethasone Impurity 56
Dexamethasone Impurity 56
CAS No.1203841-45-5
Chemical FormulaC21H27FO4
Purity>95%询价On request
10mg25mg50mg100mg
Dexamethasone Impurity 57 structure
57
地塞米松杂质57Dexamethasone Impurity 57
Dexamethasone Impurity 57
CAS No.1203841-43-3
Chemical FormulaC21H27FO4
Purity>95%询价On request
10mg25mg50mg100mg
Dexamethasone Impurity 59 structure
59
地塞米松杂质59Dexamethasone Impurity 59
Dexamethasone Impurity 59
CAS No.223776-52-1
Chemical FormulaC22H26O4
Purity>95%询价On request
10mg25mg50mg100mg
Dexamethasone Impurity 60 structure
60
地塞米松杂质60Dexamethasone Impurity 60
Dexamethasone Impurity 60
CAS No.1169872-15-4
Chemical FormulaC22H26O5
Purity>95%询价On request
10mg25mg50mg100mg
Dexamethasone Impurity 61 structure
61
地塞米松杂质61Dexamethasone Impurity 61
Dexamethasone Impurity 61
CAS No.1687742-60-4
Chemical FormulaC21H26F2O5
Purity>95%询价On request
10mg25mg50mg100mg
Dexamethasone Impurity 62 structure
62
地塞米松杂质62Dexamethasone Impurity 62
Dexamethasone Impurity 62
CAS No.1687742-59-1
Chemical FormulaC21H30F2O5
Purity>95%询价On request
10mg25mg50mg100mg
Dexamethasone Impurity 63 structure
63
地塞米松杂质63Dexamethasone Impurity 63
Dexamethasone Impurity 63
CAS No.1800-15-3
Chemical FormulaC22H27FO5
Purity>95%询价On request
10mg25mg50mg100mg
Dexamethasone Impurity 64 structure
64
地塞米松杂质64Dexamethasone Impurity 64
Dexamethasone Impurity 64
CAS No.165739-48-0
Chemical FormulaC22H29FO4
Purity>95%询价On request
10mg25mg50mg100mg
Dexamethasone Impurity 68 (Dexamethasone Decanoate) structure
68
地塞米松杂质68 (地塞米松十烷酸酯)Dexamethasone Impurity 68 (Dexamethasone Decanoate)
Dexamethasone Impurity 68 (Dexamethasone Decanoate)
CAS No.1160221-18-0
Chemical FormulaC32H47FO6
Purity>95%询价On request
10mg25mg50mg100mg
Dexamethasone Impurity 69 structure
69
地塞米松杂质69Dexamethasone Impurity 69
Dexamethasone Impurity 69
CAS No.1879-72-7
Chemical FormulaC31H37FO6
Purity>95%询价On request
10mg25mg50mg100mg
Dexamethasone Impurity 71 structure
71
地塞米松杂质71Dexamethasone Impurity 71
Dexamethasone Impurity 71
CAS No.7721-43-9
Chemical FormulaC22H29FO6
Purity>95%询价On request
10mg25mg50mg100mg
Dexamethasone Impurity 80 structure
80
地塞米松杂质80Dexamethasone Impurity 80
Dexamethasone Impurity 80
CAS No.62800-49-1
Chemical FormulaC22H27FO4
Purity>95%询价On request
10mg25mg50mg100mg
Dexamethasone Impurity 81 structure
81
地塞米松杂质81Dexamethasone Impurity 81
Dexamethasone Impurity 81
CAS No.1651862-82-6
Chemical FormulaC20H26O2
Purity>95%询价On request
10mg25mg50mg100mg
Dexamethasone Impurity 82 structure
82
地塞米松杂质82Dexamethasone Impurity 82
Dexamethasone Impurity 82
CAS No.2285-53-2
Chemical FormulaC20H25FO3
Purity>95%询价On request
10mg25mg50mg100mg
Dexamethasone Impurity 83 structure
83
地塞米松杂质83Dexamethasone Impurity 83
Dexamethasone Impurity 83
CAS No.289658-57-7
Chemical FormulaC22H28FNO7
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

地塞米松 —— 研究文献与合成路线Dexamethasone — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 地塞米松 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Dexamethasone. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Enhancing drug release from PEG-PLGA implants: The role of Hydrophilic Dexamethasone Phosphate in modulating release kinetics and degradation behavior
    Lehner E, Trutschel ML, Menzel M, et al. · European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences · 2025 · 被引 7cited 7
  2. 6'-sialyllactose prevents dexamethasone-induced muscle atrophy by controlling the muscle protein degradation pathway
    Go H, Sung NJ, Choi J, et al. · Biochemical and biophysical research communications · 2024 · 被引 3cited 3
  3. Treatment of dexamethasone and lenalidomide-resistant multiple myeloma via RAD51 degradation using PROTAC and synergistic effects with chemotherapy
    Kim S, Hwang I, Kim YK, et al. · Journal of physiology and pharmacology : an official journal of the Polish Physiological Society · 2024 · 被引 1cited 1
  4. Targeting the TLR4/NF-κB/TNF-α/MMP axis with dexamethasone attenuates glycocalyx degradation and restores microcirculatory perfusion in septic kidneys
    Fu M, Zhao J, Xu W, et al. · Scientific reports · 2026
  5. Incorporating solid-phase extraction into compendial procedures for the determination of dexamethasone and impurities in low-dose drug products
    Xu Q · Journal of pharmaceutical and biomedical analysis · 2019 · 被引 2cited 2
  6. Coupling of NIR Spectroscopy and Chemometrics for the Quantification of Dexamethasone in Pharmaceutical Formulations
    Biancolillo A, Scappaticci C, Foschi M, et al. · Pharmaceuticals (Basel, Switzerland) · 2023 · 被引 7cited 7

合成与制备工艺专利Synthesis & process patents

  1. Method for preparing dexamethasone artificial antigen
    CHUANLAI XU, YUAN YUAN, CHIFANG PENG, LIMEI YIN, et al. · 公开号 CN101161679CN101161679 · 2008
  2. Production process for dexamethasone sodium phosphate bulk medicament
    SHULI WANG, TONG ZHENG · 公开号 CN101623265CN101623265 · 2010
  3. Method for preparing dexamethasone and series products thereof
    FUJUN WANG, JINPING ZHOU, JIPING JIANG, JIAN LI · 公开号 CN101397320CN101397320 · 2009
  4. A MEDICINAL FUSIDIC ACID CREAM MADE USING SODIUM FUSIDATE AND INCORPORATING A BIOPOLYMER, MICONAZOLE, DEXAMETHASONE, AND A PROCESS TO MAKE IT
    VANANGAMUDI SULUR SUBRAMANIAM, SRINIVASAN MADHAVAN, CHULLIEL NEELAKANDAN NARAYANAN, SELVARAJ BALKRISHNANA, et al. · 公开号 WO2011101824WO2011101824 · 2011
  5. A MEDICINAL FUSIDIC ACID CREAM MADE USING SODIUM FUSIDATE AND INCORPORATING BIOPOLYMER, CLOTRIMAZOLE AND DEXAMETHASONE, AND A PROCESS TO MAKE IT
    VANANGAMUDI SULUR SUBRAMANIAM, SRINIVASAN MADHAVAN, CHULLIEL NEELAKANDAN NARAYANAN, SELVARAJ BALKRISHNANA, et al. · 公开号 WO2011101823WO2011101823 · 2011

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

地塞米松 杂质谱研究要点Dexamethasone — impurity profiling notes

下面这些是拿到 地塞米松 的 59 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 59 impurity entries for Dexamethasone, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

本品种含药典编号杂质(EP/USP)。申报时药典已收载的杂质通常需要逐项对照,建议优先备齐药典编号对照品,再补充工艺与降解杂质。This drug substance includes pharmacopoeially designated impurities (EP/USP). Monographed impurities normally need item-by-item comparison during filing, so secure the pharmacopoeial standards first, then fill in process and degradation impurities.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances